NCT01053494
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Amyloidosis, +170 more
- Locations
-
- Wake Forest University Health Sciences Winston-Salem, North Carolina, United States
Clinical trial condition
Contiguous Stage II Mantle Cell Lymphoma
Explore clinical trials studying Contiguous Stage II Mantle Cell Lymphoma. Study availability and eligibility vary by location and protocol.
20 public trials
0 recruiting studies
Contiguous Stage II Mantle Cell Lymphoma trial results
NCT00601718
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +83 more
- Locations
-
- Puget Sound Oncology Consortium Seattle, Washington, United States
NCT00112593
- Conditions
- AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +281 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT01959477
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +202 more
- Locations
-
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT00343798
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, +145 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
- University of Colorado Denver, Colorado, United States
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Combination Chemotherapy and Rituximab in Treating Patients With Untreated Mantle Cell Lymphoma
NCT00433537
- Conditions
- Contiguous Stage II Mantle Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Eastern Cooperative Oncology Group Boston, Massachusetts, United States
NCT00058227
- Conditions
- B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +71 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
NCT00891072
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Blood Protein Disorders, +121 more
- Locations
-
- Cancer Institute of New Jersey New Brunswick, New Jersey, United States
NCT00017381
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +78 more
- Locations
-
- Johns Hopkins University Baltimore, Maryland, United States
Active, Not Recruiting
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
NCT01199562
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +245 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States